Updates on HIV and Kidney Disease

Overview

Journal Curr HIV/AIDS Rep

Publisher Current Science

Specialty Infectious Diseases

Date 2023 Jan 25

PMID 36695948

Authors

C Elena Cervantes

Mohamed G Atta

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: With the advent of antiretroviral therapy, HIV infection has become a chronic disease in developed countries.

Recent Findings: Non-HIV-driven risk factors for kidney disease, such as APOL1 risk variants and other genetic and environmental factors, have been discovered and are better described. Consequently, the field of HIV-associated kidney disease has evolved with greater attention given to traditional risk factors of CKD and antiretroviral treatment's nephrotoxicity. In this review, we explore risk factors of HIV-associated kidney disease, diagnostic tools, kidney pathology in HIV-positive individuals, and antiretroviral therapy-associated nephrotoxicity.

Citing Articles

Cardiac and Renal Comorbidities in Aging People Living With HIV.

McCutcheon K, Nqebelele U, Murray L, Thomas T, Mpanya D, Tsabedze N Circ Res. 2024; 134(11):1636-1660.

PMID: 38781295 PMC: 11122746. DOI: 10.1161/CIRCRESAHA.124.323948.

The iron group transition-metal (Fe, Ru, Os) coordination of Se-doped graphitic carbon (Se@g-CN) nanostructures for the smart therapeutic delivery of zidovudine (ZVD) as an antiretroviral drug: a theoretical calculation perspective.

Nelson F, Louis H, Benjamin I, A Timothy R RSC Adv. 2023; 13(48):34078-34096.

PMID: 38020013 PMC: 10660211. DOI: 10.1039/d3ra06885d.

References

Wong C, Gange S, Buchacz K, Moore R, Justice A, Horberg M . First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clin Infect Dis. 2017; 64(4):459-467. PMC: 5850614. DOI: 10.1093/cid/ciw804. View

Heron J, Bagnis C, Gracey D . Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020; 17(1):11. PMC: 7075008. DOI: 10.1186/s12981-020-00266-3. View

Gameiro J, Agapito Fonseca J, Jorge S, Lopes J . Acute kidney injury in HIV-infected patients: a critical review. HIV Med. 2018; 20(2):77-87. DOI: 10.1111/hiv.12685. View

Abraham A, Althoff K, Jing Y, Estrella M, Kitahata M, Wester C . End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2014; 60(6):941-9. PMC: 4357817. DOI: 10.1093/cid/ciu919. View

Nichols B, Jog P, Lee J, Blackler D, Wilmot M, DAgati V . Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int. 2014; 87(2):332-42. PMC: 4312530. DOI: 10.1038/ki.2014.270. View

Kruzel-Davila E, Shemer R, Ofir A, Bavli-Kertselli I, Darlyuk-Saadon I, Oren-Giladi P . APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes. J Am Soc Nephrol. 2016; 28(4):1117-1130. PMC: 5373454. DOI: 10.1681/ASN.2016050546. View

Beckerman P, Bi-Karchin J, Park A, Qiu C, Dummer P, Soomro I . Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017; 23(4):429-438. PMC: 5603285. DOI: 10.1038/nm.4287. View

Limou S, Nelson G, Kopp J, Winkler C . APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis. 2014; 21(5):426-33. PMC: 4157456. DOI: 10.1053/j.ackd.2014.06.005. View

Genovese G, Friedman D, Ross M, Lecordier L, Uzureau P, Freedman B . Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329(5993):841-5. PMC: 2980843. DOI: 10.1126/science.1193032. View

10.

Kopp J, Nelson G, Sampath K, Johnson R, Genovese G, An P . APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011; 22(11):2129-37. PMC: 3231787. DOI: 10.1681/ASN.2011040388. View

11.

Dummer P, Limou S, Rosenberg A, Heymann J, Nelson G, Winkler C . APOL1 Kidney Disease Risk Variants: An Evolving Landscape. Semin Nephrol. 2015; 35(3):222-36. PMC: 4562465. DOI: 10.1016/j.semnephrol.2015.04.008. View

12.

Fine D, Wasser W, Estrella M, Atta M, Kuperman M, Shemer R . APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol. 2011; 23(2):343-50. PMC: 3269183. DOI: 10.1681/ASN.2011060562. View

13.

Atta M, Estrella M, Kuperman M, Foy M, Fine D, Racusen L . HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int. 2012; 82(3):338-43. PMC: 3463138. DOI: 10.1038/ki.2012.111. View

14.

Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D . Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One. 2012; 7(7):e40245. PMC: 3401192. DOI: 10.1371/journal.pone.0040245. View

15.

Shen T, Huang K, Chao C, Wang Y, Muo C, Wei C . The risk of chronic kidney disease in tuberculosis: a population-based cohort study. QJM. 2014; 108(5):397-403. DOI: 10.1093/qjmed/hcu220. View

16.

Jha V, Prasad N . CKD and Infectious Diseases in Asia Pacific: Challenges and Opportunities. Am J Kidney Dis. 2016; 68(1):148-60. DOI: 10.1053/j.ajkd.2016.01.017. View

17.

Hung R, Binns-Roemer E, Booth J, Hilton R, Fox J, Burns F . Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV. Kidney Int Rep. 2022; 7(3):465-473. PMC: 8897676. DOI: 10.1016/j.ekir.2021.12.007. View

18.

Choi A, Li Y, Parikh C, Volberding P, Shlipak M . Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int. 2010; 78(5):478-85. PMC: 3913062. DOI: 10.1038/ki.2010.171. View

19.

Likanonsakul S, Suntisuklappon B, Nitiyanontakij R, Prasithsirikul W, Nakayama E, Shioda T . A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection. PLoS One. 2016; 11(1):e0147724. PMC: 4726597. DOI: 10.1371/journal.pone.0147724. View

20.

Thompson M, Horberg M, Agwu A, Colasanti J, Jain M, Short W . Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2020; 73(11):e3572-e3605. DOI: 10.1093/cid/ciaa1391. View